{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:10:16Z","timestamp":1790838616990,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124391","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:53:56Z","timestamp":1781798036000},"page":"124391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nanozyme-augmented clinical drug strategy for dopaminergic restoration and oxidative stress mitigation to rescue motor and cognitive deficits in Parkinson's disease"],"prefix":"10.1016","volume":"335","author":[{"given":"Yinyao","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaolin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-2964","authenticated-orcid":false,"given":"Xuesheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-5735","authenticated-orcid":false,"given":"Hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.biomaterials.2026.124391_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"10423","key":"10.1016\/j.biomaterials.2026.124391_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"7704","key":"10.1016\/j.biomaterials.2026.124391_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41586-018-0090-6","article-title":"Diametric neural ensemble dynamics in parkinsonian and dyskinetic states","volume":"557","author":"Parker","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124391_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.143245","article-title":"ROS-Responsive hierarchical targeting vehicle-free nanodrugs for three-pronged Parkinson's disease therapy","volume":"466","author":"Fan","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in parkinson's disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2026.124391_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nbd.2014.01.017","article-title":"Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease","volume":"65","author":"Darvas","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biomaterials.2026.124391_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.26078","article-title":"Novel formulations and modes of delivery of levodopa","volume":"30","author":"Poewe","year":"2015","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124391_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2026.124391_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-2999(03)02087-9","article-title":"Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms","volume":"475","author":"Ramirez","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124391_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and akt kinase","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124391_bib13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.neuropsychologia.2009.01.039","article-title":"Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory","volume":"47","author":"Costa","year":"2009","journal-title":"Neuropsychologia"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124391_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00702-002-0811-7","article-title":"Pramipexole in comparison to l-dopa: a neuropsychological study","volume":"110","author":"Brusa","year":"2003","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-1331.2004.00966.x","article-title":"Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy","volume":"12","author":"Rektorova","year":"2005","journal-title":"Eur. J. Neurol."},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124391_bib16","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","article-title":"Classics in chemical neuroscience: pramipexole","volume":"11","author":"Wilson","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biomaterials.2026.124391_bib18","volume":"2010","author":"Eisenreich","year":"2010"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124391_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/NDT.S2325","article-title":"Update on the use of pramipexole in the treatment of Parkinson's disease","volume":"4","author":"Constantinescu","year":"2008","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124391_bib22","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.lfs.2007.01.035","article-title":"Blood-brain barrier transport of pramipexole, a dopamine D2 agonist","volume":"80","author":"Okura","year":"2007","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124391_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s44222-024-00205-1","article-title":"Designing nanozymes for in vivo applications","volume":"2","author":"Zhang","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124391_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211210","article-title":"Multienzyme-like nanozymes: regulation, rational design, and application","volume":"36","author":"Sheng","year":"2024","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124391_bib25","article-title":"Exploring the neuroprotective role of selenium: implications and perspectives for central nervous system disorders","volume":"5","author":"Huang","year":"2025","journal-title":"Explorations"},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124391_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206959","article-title":"Peptide-functionalized prussian blue nanomaterial for antioxidant stress and NIR photothermal therapy against Alzheimer's disease","volume":"19","author":"Song","year":"2023","journal-title":"Small"},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124391_bib27","doi-asserted-by":"crossref","first-page":"33567","DOI":"10.1021\/acsnano.5c11417","article-title":"Hybrid exosome-liposome nanoparticles for dual modulation of neuroinflammation and lipid metabolism in ischemic stroke","volume":"19","author":"Xie","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124391_bib28","article-title":"Mannose-coated superparamagnetic iron oxide nanozyme for preventing postoperative cognitive dysfunction, materials today","volume":"19","author":"Zhu","year":"2023","journal-title":"Bio"},{"issue":"39","key":"10.1016\/j.biomaterials.2026.124391_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202405190","article-title":"Emerging nanozymes in neurological disorder therapeutics: bridging oxidoreductase mimicry and antioxidant chemistry","volume":"34","author":"Jiang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124391_bib30","first-page":"531","article-title":"KNC nanozyme repairs hypoxia ischemia brain damage through ALOX12 mediated lipid peroxidation inhibition","volume":"54","author":"Dong","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2026.124391_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121904","article-title":"Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke","volume":"291","author":"Li","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib32","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1038\/s41467-023-43870-3","article-title":"Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson's disease","volume":"14","author":"Jiang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124391_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113950","article-title":"Targeting ferroptosis and mitophagy with neutrophil-inspired nanozyme for Parkinson's disease therapy","volume":"384","author":"Tian","year":"2025","journal-title":"J. Contr. Release"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124391_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106723","article-title":"Prussian blue nanozyme as a pyroptosis inhibitor alleviates neurodegeneration","volume":"34","author":"Ma","year":"2022","journal-title":"Adv. Mater."},{"issue":"52","key":"10.1016\/j.biomaterials.2026.124391_bib35","doi-asserted-by":"crossref","first-page":"21730","DOI":"10.1021\/jacs.0c09390","article-title":"Targeting microglia for therapy of Parkinson's disease by using biomimetic ultrasmall nanoparticles","volume":"142","author":"Liu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124391_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100316","article-title":"Catalytic-enhanced lactoferrin-functionalized Au-Bi(2) Se(3) nanodots for Parkinson's disease therapy via reactive oxygen attenuation and mitochondrial protection","volume":"10","author":"Li","year":"2021","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124391_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biomaterials.2018.12.013","article-title":"Gold nanoclusters for Parkinson's disease treatment","volume":"194","author":"Gao","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124391_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/NDT.S10097","article-title":"Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson's disease: implications for patients","volume":"7","author":"Antonini","year":"2011","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwac167","article-title":"Liposomes embedded with PEGylated iron oxide nanoparticles enable ferroptosis and combination therapy in cancer","volume":"10","author":"Liu","year":"2023","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.biomaterials.2026.124391_bib40","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S123422","article-title":"Angiopep-2-conjugated poly(ethylene glycol)-co- poly(epsilon-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats","volume":"12","author":"Lu","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124391_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17070885","article-title":"Advances in liposomal drug delivery: multidirectional perspectives on overcoming biological barriers","volume":"17","author":"Sobol","year":"2025","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124391_bib42","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124391_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126463","article-title":"Fe(3)O(4) nanozymes improve neuroblast differentiation and blood-brain barrier integrity of the hippocampal dentate gyrus in D-Galactose-Induced aged mice","volume":"23","author":"Xia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124391_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202214826","article-title":"A dual synergetic nanoreactor for managing Parkinson's disease by regulating inflammation and mitigating oxidative damage","volume":"33","author":"Li","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124391_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/polym14040712","article-title":"Angiopep-2-Modified nanoparticles for brain-directed delivery of therapeutics: a review","volume":"14","author":"Habib","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124391_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00702-018-1903-3","article-title":"Human tyrosine hydroxylase in Parkinson's disease and in related disorders","volume":"126","author":"Nagatsu","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biomaterials.2026.124391_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100994","article-title":"Dopamine D3 receptor: a neglected participant in Parkinson disease pathogenesis and treatment?","volume":"57","author":"Yang","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124391_bib49","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1364\/BOE.6.003919","article-title":"Multi-channel fiber photometry for population neuronal activity recording","volume":"6","author":"Guo","year":"2015","journal-title":"Biomed. Opt. Express"},{"key":"10.1016\/j.biomaterials.2026.124391_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2014.11.023","article-title":"Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia","volume":"91","author":"Hsu","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(96)00454-2","article-title":"Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists","volume":"312","author":"Piercey","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124391_bib52","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/npp.2008.114","article-title":"Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain","volume":"34","author":"Chernoloz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biomaterials.2026.124391_bib53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124391_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108156","article-title":"Functional dissection of basal ganglia inhibitory inputs onto Substantia Nigra dopaminergic neurons","volume":"32","author":"Evans","year":"2020","journal-title":"Cell Rep."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2026.124391_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-2999(03)02080-6","article-title":"Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration","volume":"474","author":"Truong","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124391_bib56","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s12035-016-9743-3","article-title":"Oxidative modification and its implications for the neurodegeneration of Parkinson's disease","volume":"54","author":"Zhao","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biomaterials.2026.124391_bib57","volume":"2022","author":"Cheng","year":"2022"},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124391_bib58","article-title":"Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson's disease","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.biomaterials.2026.124391_bib59","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jconrel.2024.03.010","article-title":"Focused ultrasound-mediated cerium-based nanoreactor against Parkinson's disease via ROS regulation and microglia polarization","volume":"368","author":"Gao","year":"2024","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jphs.2018.08.008","article-title":"Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease","volume":"138","author":"Wang","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124391_bib61","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/0269881117714051","article-title":"Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease","volume":"31","author":"Loiodice","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124391_bib62","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.neuron.2023.03.021","article-title":"Cognitive heterogeneity in Parkinson's disease: a mechanistic view","volume":"111","author":"Carceles-Cordon","year":"2023","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hipo.20607","article-title":"The role of medial temporal lobe in retrieving spatial and nonspatial relations from episodic and semantic memory","volume":"20","author":"Ryan","year":"2010","journal-title":"Hippocampus"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124391_bib64","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrn2335","article-title":"The hippocampus and memory: insights from spatial processing","volume":"9","author":"Bird","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biomaterials.2026.124391_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.parkreldis.2021.01.002","article-title":"Cognitive impairment in Parkinson's disease is associated with default mode network subsystem connectivity and cerebrospinal fluid Abeta","volume":"83","author":"Zarifkar","year":"2021","journal-title":"Park. Relat. Disord."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124391_bib66","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1162\/jocn.2009.21138","article-title":"Distinct hippocampal and basal ganglia contributions to probabilistic learning and reversal","volume":"21","author":"Shohamy","year":"2009","journal-title":"J. Cognit. Neurosci."},{"key":"10.1016\/j.biomaterials.2026.124391_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cortex.2018.11.021","article-title":"Episodic recognition memory and the hippocampus in Parkinson's disease: a review","volume":"113","author":"Das","year":"2019","journal-title":"Cortex"},{"issue":"39","key":"10.1016\/j.biomaterials.2026.124391_bib68","doi-asserted-by":"crossref","first-page":"46213","DOI":"10.1021\/acsami.1c06449","article-title":"A Co-Doped Fe(3)O(4) nanozyme shows enhanced reactive oxygen and nitrogen species scavenging activity and ameliorates the deleterious effects of ischemic stroke","volume":"13","author":"Liu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124391_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110265","article-title":"Dopamine depletion selectively disrupts interactions between striatal neuron subtypes and LFP oscillations","volume":"38","author":"Zemel","year":"2022","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124391_bib70","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awab242","article-title":"Dopamine-dependent early synaptic and motor dysfunctions induced by alpha-synuclein in the nigrostriatal circuit","volume":"144","author":"Tozzi","year":"2021","journal-title":"Brain"},{"issue":"7458","key":"10.1016\/j.biomaterials.2026.124391_bib71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12354","article-title":"Ultrasensitive fluorescent proteins for imaging neuronal activity","volume":"499","author":"Chen","year":"2013","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124391_bib72","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41592-020-00981-9","article-title":"Next-generation GRAB sensors for monitoring dopaminergic activity in vivo","volume":"17","author":"Sun","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biomaterials.2026.124391_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.898164","article-title":"High-power electromagnetic pulse exposure of healthy mice: assessment of effects on mice cognitions, neuronal activities, and hippocampal structures","volume":"16","author":"Hao","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124391_bib74","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1038\/s41467-023-42283-6","article-title":"The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption","volume":"14","author":"Ding","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:17:20Z","timestamp":1785359840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":72,"alternative-id":["S0142961226004151"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124391","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanozyme-augmented clinical drug strategy for dopaminergic restoration and oxidative stress mitigation to rescue motor and cognitive deficits in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124391"}}